Advancing Cardiometabolic Clinical Research

Investigative sites for cardiometabolic and endocrine clinical trials

Find the right patients for your cardiometabolic trial

By leveraging relationships with premier endocrinology centers, Tekton offers access to highly specialized patient populations. These sites are led by physicians who fully support clinical research, and several of our physician-investigators are leading regional providers for diabetes care and obesity. These sites also have active practice databases, providing access to patients who may consider clinical trials as a care option.

+
Tekton sites supporting cardiometabolic clinical trials
Sites with extensive diabetes and obesity expertise and capabilities
Investigators board-certified in endocrinology, diabetes & metabolism

Therapeutic Experience

Tekton Research's expertise spans the full spectrum of cardiometabolic research, including but not limited to:

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Obesity
  • Hypothyroidism/Hyperthyroidism
  • Lipids
  • Hypertension
  • PCOS
  • Osteoporosis
  • Growth Hormone Deficiencies
  • Parathyroid Disorders
  • Thyroid Disorders
  • Pituitary disorders
  • Adrenal Gland Disorders
  • Fatty liver

Why Choose Tekton for Your Next Cardiometabolic Study

Specialized Metabolic and Cardiovascular Experience

Our investigators are leaders in cardiometabolic research with proven track records in diabetes, obesity, and cardiovascular-focused clinical trials

Patient-Centered Approach

Access to diverse patient populations and streamlined recruitment strategies specific to cardiometabolic conditions

Research-Optimized Facilities

Purpose-built environments equipped with the latest cardiac monitoring tools, metabolic testing equipment, and specialized technologies

Regulatory Excellence

Comprehensive understanding of the unique regulatory considerations in cardiometabolic research

Data Integrity

Meticulous attention to detail in all aspects of data collection and management for complex metabolic studies

High-Volume Trials

Dedicated research centers and general medicine sites to support high-volume trials for common conditions, such as type 2 diabetes, hypertension, and obesity

Leading Sites and Endocrinologists to Support Groundbreaking Research

Beyond our endocrinology sites, Tekton has dedicated research centers and internists that support high-volume trials for more common conditions, such as T2D and obesity.

Featured Endocrinologists & Internists

Pablo Mora, MD, FACE, MSc, CDCES

Dr. Pablo F. Mora is a renowned Diabetes, Metabolism & Endocrinology KOL (Key Opinion Leader) with 30 years of experience in cardiometabolic care. He specializes in Type 1 Diabetes with emphasis on new insulin delivery methods and the use of modern technology for monitoring and making therapeutic decisions, and has experience with rare diseases such as Sjögren’s syndrome. Dr. Mora serves as a Clinical Professor at University of Texas Southwestern Medical Center’s Division of Endocrinology and has received several prestigious recognitions for his contributions to the field, including the Daniel Foster Award for Clinical Teaching by the Division of Endocrinology at UT Southwestern Medical Center.

Jara McDonald, MD, FAAP, Principal Investigator at Tekton Research

Jara McDonald, MD, FAAFP

Dr. Jara McDonald is an Obesity, Diabetes, and Integrative Medicine Specialist with over 10 years of experience in cardiometabolic care and 4 years in clinical research. She owns and operates her own integrative direct primary care (DPC) practice focused on evidence-based mind-body wellness and integration of leading-edge research, providing personalized weight management care and individualized patient success plans. Her DPC model allows for increased patient access and facilitates in-depth discussions about research studies, enabling her to provide comprehensive care that incorporates the latest medical evidence.

clinical research endocrinology

Partner With Us

Join the leading sponsors and CROs who trust Tekton Research with their most important cardiometabolic clinical trials. Contact us today to discuss how our specialized expertise can help bring your next breakthrough treatment to patients in need.